Managed Care Newsletter
Matters Prescriptions Made Simple
Quest Diagnostics now
offers Care360™ ePrescribing
Electronic prescribing offers the opportunity
A New Test Means Better Care for for significant quality improvements and
significant cost savings – estimated to be as
Metastatic Breast Cancer Patients much as $27 billion industry-wide.
Quest Diagnostics now offers the CellSearch™
Quest Diagnostics, a leader in physician
Circulating Tumor Cell Kit
connectivity products, has launched an
Quest Diagnostics recently agreed with Veridex, LLC, a Johnson & Johnson ePrescribing module within our Care360
company, to be the only national commercial reference laboratory to offer physician offering.
Veridex’s CellSearch Circulating Tumor Cell Kit. CellSearch is a new cancer
Now, there’s a simpler, easier way for your
diagnostic technology that identifies and counts circulating tumor cells in
physicians to order, refill and manage patient
blood samples from patients being treated for metastatic breast cancer.
prescriptions and help eliminate data
In January 2004, the U.S. Food and Drug Administration cleared CellSearch omissions and errors.
to be used for the enumeration of circulating tumor cells of epithelial origin
Care360 ePrescribing offers:
in whole blood.
Electronic script submission
Circulating tumor cells are present in the blood when a primary cancer Formulary presentation through RxHub
sheds tumor cells into the circulatory system. Cancer metastasis occurs
or payer-specific uploads
when circulating tumor cells begin to grow in distant locations in the body.
Diagnostic lab history
The ability to identify and count circulating tumor cells has the potential
to improve the care oncologists administer to their patients with metastatic
breast cancer. Drug-to-drug and drug-to-allergy
Knowing the number of circulating tumor cells in the blood may help
Integration with existing physician office
oncologists make decisions about patients’ treatment earlier than previously
possible. Until now, physicians had to wait three months or longer before
they could use medical imaging to determine if a specific treatment was Anytime, anywhere access
beneficial to the patient. Care360 ePrescribing reduces paperwork
“This important new test has the potential to help oncologists better care because prescriptions are charted electroni-
for patients with metastatic breast cancer,” said Surya N. Mohapatra, Ph.D., cally, alongside lab results, thereby reducing
President and Chief Executive Officer at Quest Diagnostics. “We are excited dependency on paper charts for filling
to offer this test, which strengthens our position in oncology testing as a prescriptions or responding to inquiries.
trusted resource for doctors and their patients.” ePrescribing also increases time for patient
care by reducing time spent on the phone
CellSearch’s value was substantiated by a study published on August 19, 2004, with pharmacies – allowing a new prescription
in the New England Journal of Medicine, which demonstrated that the number to be created and sent in three easy steps.
of circulating tumor cells is predictive of progression-free survival and overall The service also enhances quality of care by
survival in metastatic breast cancer patients. identifying drug-interactions within a pre-
For more information about CellSearch Circulating Tumor Cells, please call scription and efficiently sharing patient lab
Quest Diagnostics Nichols Institute toll-free at 800-642-4657, extension 2906. and prescription history with other Care360
Cristofanilli, M, Budd, GT, Ellis, MJ, et al. Circulating Tumor Cells, Disease Progression, and Survival in
Metastatic Breast Cancer. N Engl J Med. 2004; 351:781–791. continued on page 2
Quest Diagnostics Presents: An Appropriate Partner
The Art of Women’s Health A partnership with Quest Diagnostics
A seven-part television series focusing on current women’s issues helps ensure successful launch, training
Did you know? and deployment and, most importantly,
Women can lose up to 20 percent of their bone mass in the five to seven provider adoption.
years following menopause, making them more susceptible to osteoporosis.i Relationships with 300,000 physician
Of the 78,054 babies born each week in the U.S., 8,826 of those babies customers
are born to mothers who received inadequate prenatal care.ii 800 trained and dedicated Sales
Approximately 6.1 million American women are affected by infertility.iii Representatives
It is estimated that 231,910 American women will die from breast cancer 200 locally distributed Field IT Staff
this year alone.iv
24 x 7 Help Desk Support
Every minute, one woman dies from cardiovascular disease.v
Integrated into the existing workflow
In an effort to inform more and more women about the challenging health
of providers nationally
issues facing them today, Quest Diagnostics is underwriting ‘The Art of
Women’s Health,’ a seven-part series that will begin airing on PBS in April A prescription management component of
2005. Viewers will have the chance to hear inspiring stories from a number the eMaxx® Physician Portal, ePrescribing
of women as they recount their experiences with some of the following simply requires a PC and high-speed
health issues: fertility, well-women exams, prenatal care, heart disease, Internet access to deliver significant time
breast cancer and osteoporosis, to name a few. and cost-savings to its users. For more
As a leader in women’s health, Quest Diagnostics is proud to help underwrite information about Care360 Physician Office
this unique series as part of our commitment to our patients. Supporting Solutions contact your Quest Diagnostics
today’s women with comprehensive testing and information is one of Quest Account Executive.
Diagnostics’ most important goals.
National Osteoporosis Foundation, http://www.nof.org/osteoporosis/diseasefacts.htm
March of Dimes, http://www.marchofdimes.com/peristats/ataglance/99.pdf
American Society for Reproductive Medicine
American Cancer Society, 2004.
Heart Disease and Stroke Statistics – 2004 Update, American Heart Association
We look forward to seeing you at these conferences!
have been assembled for this meeting.
most experienced and forward-thinking leaders
unique, discussion-based forum. Some of the
solutions, as it will convene all stakeholders in a
significant strides in implementing actionable
cance. The 2005 conference hopes to achieve
conference initiated a dialog of national signifi-
Wall Street Journal and CNBC, the 2004 executive
through February 1, 2005. Co-sponsored by the
Washington D.C. is scheduled from January 30
The 2nd Annual World Health Care Congress in
2005 World Health Care Congress
is now demanding.
the quality measures the consumerism movement
California. The Forum will focus on PPOs, and
Laguna Niguel Spa and Resort in Dana Point,
January 23 through 25, 2005, at the Ritz-Carlton’s
The 2005 Annual PPO Forum is scheduled from
American Association of Preferred Provider
GRAPHICS Pennshauken, NJ 08110 conferences in early 2005:
CONTEMPORARY 1533 Union Avenue we will be participating at the following
c/o Contemporary Graphics Quest Diagnostics is pleased to announce that
FIRST CLASS MAIL Coming Soon to a Conference Near You